OnCore Login

Return to Trial Database

HCRN-QL01-26

A Phase II Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients Receiving Chemotherapy

Status

Study Completed

Cancer Type(s)

Quality of Life

Study Contact

Publications

A Phase II Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients Receiving Chemotherapy
  • RM Navari, LH Einhorn, PJ Loehrer, SD Passik, J Vinson, ML Mayer, W Pletcher, J McClean
A Phase II Trial of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
  • RM Navari, LH Einhorn, SD Passik, PJ Loehrer Sr., C Johnson, ML Mayer, J McClean, J Vinson, W Pletcher
A Pilot Exploration of the Antiemetic Activity of Olanzapine for the Relief of Nausea in Patients with Advanced Cancer and Pain
  • SD Passik, J Lundberg, KL Kirsh, D Theobald, K Donaghy, E Holtsclaw, M Cooper, W Dugan

Trial Locations

All sites in which the trial HCRN-QL01-26 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278